Article Link: Bausch Health Announces U.S. Launch of Bryhali (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis In Adults LAVAL...
FDA Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma
Article Link: FDA Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relap...
FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta
Article Link: FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) &#...
FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer
Article Link: FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer November 2, 20...
FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain
Article Link: FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ —...
FDA Approves Sympazan (clobazam) Oral Film for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
Article Link: FDA Approves Sympazan (clobazam) Oral Film for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome WAR...
FDA Approves Hyrimoz (adalimumab-adaz), a Biosimilar to Humira
Article Link: FDA Approves Hyrimoz (adalimumab-adaz), a Biosimilar to Humira Holzkirchen, Germany, October 31, 2018 – Sandoz, a Nov...
FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause
Article Link: FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause�...
FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza
Article Link: FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza October 24, 2018 — Today...
Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
Article Link: Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection HENDERSON, Nev.–(BUSINESS W...
